Artwork

Content provided by Purple Pen Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Purple Pen Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

PPP136 - Type II Diabetes

27:12
 
Distribuie
 

Manage episode 340770817 series 1295979
Content provided by Purple Pen Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Purple Pen Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Kristin is joined by Dr Priya Sumithran, Endocrinologist and Clinician Researcher, to talk about treatment options for the management of type II diabetes. Priya leads the Obesity Research Group at the University of Melbourne, Department of Medicine (St Vincent’s) and is Head of Obesity Medicine at Austin Health.

*Note Wegovy (semaglutide) was not registered in Australia at the time of recording but has since been registered with the TGA (1st September 2022).

PBAC Public Summary Document - Wegovy (semaglutide) - March 2022 consideration

  continue reading

137 episoade

Artwork

PPP136 - Type II Diabetes

Purple Pen Podcast

14 subscribers

published

iconDistribuie
 
Manage episode 340770817 series 1295979
Content provided by Purple Pen Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Purple Pen Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Kristin is joined by Dr Priya Sumithran, Endocrinologist and Clinician Researcher, to talk about treatment options for the management of type II diabetes. Priya leads the Obesity Research Group at the University of Melbourne, Department of Medicine (St Vincent’s) and is Head of Obesity Medicine at Austin Health.

*Note Wegovy (semaglutide) was not registered in Australia at the time of recording but has since been registered with the TGA (1st September 2022).

PBAC Public Summary Document - Wegovy (semaglutide) - March 2022 consideration

  continue reading

137 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință